Last week an FDA advisory panel recommended people over the age of 65 and those at high risk should be eligible. Tonight the agency authorized the Pfizer Covid booster for emergency use for that group.
New data has revealed the devastating impact that the Covid-19 learning loss has had on underserved communities. NBC News’ Heidi Pryzblya spoke with a single mother in Chicago about the challenges her family has faced with schooling during the pandemic.
A CDC panel kicked off a two day meeting weighing whether Americans should get a Pfizer Covid-19 booster shot and who should get them. The FDA is expected to make a final decision after a separate panel rejected Pfizer boosters for most Americans. NBC News’ Stephanie Gosk reports.